K

Kazia Therapeutics Limited
D

KZIA

0.88500
USD
0.02
(2.31%)
مغلق
حجم التداول
353
الربح لكل سهم
-8
العائد الربحي
-
P/E
-0
حجم السوق
4,946,525
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AGEN
    -0.11500
    (-3.34%)
    3.33000 USD
    A
    ARCT
    0.846
    (5.00%)
    17.770 USD
    B
    BNTC
    -0.340
    (-2.90%)
    11.400 USD
    BNTX
    BNTX
    2.240
    (1.90%)
    120.100 USD
    C
    CRVS
    -0.22000
    (-4.99%)
    4.19000 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    N
    NVAX
    0.05500
    (0.69%)
    7.98000 USD
    V
    VYGR
    -0.04000
    (-0.94%)
    4.22500 USD
    المزيد
الأخبار
المقالات

العنوان: Kazia Therapeutics Limited

القطاع: Healthcare
الصناعة: Biotechnology
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.